466 related articles for article (PubMed ID: 10782363)
21. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
22. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
[TBL] [Abstract][Full Text] [Related]
23. An update on medical management of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Tanda ML; Piantanida E; Lai A; Marinò M; Pinchera A
J Endocrinol Invest; 2005 May; 28(5):469-78. PubMed ID: 16075933
[TBL] [Abstract][Full Text] [Related]
24. [Severe endocrine ophthalmopathy. A review with case reports].
Barth A; Bosshard C; Bürgi U; Bürgi H
Schweiz Med Wochenschr; 1991 Jan; 121(1-2):3-9. PubMed ID: 1899292
[TBL] [Abstract][Full Text] [Related]
25. Clinical update: treatment of hyperthyroidism in Graves' ophthalmopathy.
Azzam I; Tordjman K
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():193-7. PubMed ID: 20467362
[TBL] [Abstract][Full Text] [Related]
26. Orbital radiotherapy for Graves' ophthalmopathy.
Bartalena L; Marcocci C; Tanda ML; Rocchi R; Mazzi B; Barbesino G; Pinchera A
Thyroid; 2002 Mar; 12(3):245-50. PubMed ID: 11952048
[TBL] [Abstract][Full Text] [Related]
27. Severe Graves' ophthalmopathy after retrobulbar anesthesia for cataract extraction in a patient with mild stable thyroid eye disease.
Wai DC; Ho SC; Seah LL; Fong KS; Khoo DH
Thyroid; 2003 Aug; 13(8):823-6. PubMed ID: 14558926
[TBL] [Abstract][Full Text] [Related]
28. Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy.
Marcocci C; Marinò M; Rocchi R; Menconi F; Morabito E; Pinchera A
J Endocrinol Invest; 2004 Mar; 27(3):272-80. PubMed ID: 15165004
[TBL] [Abstract][Full Text] [Related]
29. Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy.
Bahn RS; Gorman CA
Endocrinol Metab Clin North Am; 1987 Jun; 16(2):391-407. PubMed ID: 3319588
[TBL] [Abstract][Full Text] [Related]
30. Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management.
El-Kaissi S; Frauman AG; Wall JR
Intern Med J; 2004 Aug; 34(8):482-91. PubMed ID: 15317547
[TBL] [Abstract][Full Text] [Related]
31. High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves' ophthalmopathy.
Pigeon P; Orgiazzi J; Berthezene F; Gerard JP; Haguenauer JP; Mornex R
Horm Res; 1987; 26(1-4):172-6. PubMed ID: 3110042
[TBL] [Abstract][Full Text] [Related]
32. [Corticosteroids and radiotherapy in the treatment of Graves' ophthalmopathy].
Nasr E; Khater S; Nehme-Nasr D; Azoury F; Jambart S
J Med Liban; 2010; 58(2):86-90. PubMed ID: 20549894
[TBL] [Abstract][Full Text] [Related]
33. Current and Future Treatments for Graves' Disease and Graves' Ophthalmopathy.
Kotwal A; Stan M
Horm Metab Res; 2018 Dec; 50(12):871-886. PubMed ID: 30286486
[TBL] [Abstract][Full Text] [Related]
34. Novel approaches to the management of graves' ophthalmopathy.
Bartalena L; Tanda ML; Medea A; Marcocci C; Pinchera A
Hormones (Athens); 2002; 1(2):76-90. PubMed ID: 17110359
[TBL] [Abstract][Full Text] [Related]
35. Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey.
Weetman AP; Wiersinga WM
Clin Endocrinol (Oxf); 1998 Jul; 49(1):21-8. PubMed ID: 9797843
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic orbital decompression for Graves' ophthalmopathy.
Levy J; Puterman M; Lifshitz T; Marcus M; Segal A; Monos T
Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804
[TBL] [Abstract][Full Text] [Related]
37. [The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results].
Antonelli A; Saracino A; Alberti B; Melosi A; Cartei F; Lepri A; Laddaga M; Baschieri L
Clin Ter; 1992 Jan; 140(1):25-31. PubMed ID: 1526094
[TBL] [Abstract][Full Text] [Related]
38. [Graves' orbitopathy].
Balázs C
Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
[TBL] [Abstract][Full Text] [Related]
39. [Titers of antibodies against thyroid membrane antigens in patients with Graves-Basedow disease and progressive infiltrative ophthalmopathy during treatment with glucocorticoids and retro-orbital tissue irradiation].
Pilarska K; Syrenicz A; Czekalski S; Gołebiowska I; Andrzejewska W; Krzystolik Z
Pol Tyg Lek; 1991 Oct 28-Nov 4; 46(43-44):824-6. PubMed ID: 1669170
[TBL] [Abstract][Full Text] [Related]
40. Thyroid eye disease: therapy in the active phase.
Bhatti MT; Dutton JJ
J Neuroophthalmol; 2014 Jun; 34(2):186-97. PubMed ID: 24821102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
